Marshall Wace Portfolio holdings
AUM
$84.1B
This Quarter Return
+8.75%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$38.8B
AUM Growth
+$38.8B
(-2.5%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.91%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
3,658
New
596
Increased
589
Reduced
695
Closed
821
Top Buys
| 1 |
Exxon Mobil
XOM
|
$311M |
| 2 |
Biogen
BIIB
|
$303M |
| 3 |
Nike
NKE
|
$268M |
| 4 |
Alibaba
BABA
|
$261M |
| 5 |
Citigroup
C
|
$252M |
Top Sells
| 1 |
Humana
HUM
|
$383M |
| 2 |
Johnson & Johnson
JNJ
|
$319M |
| 3 |
JPMorgan Chase
JPM
|
$301M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$232M |
| 5 |
Boston Scientific
BSX
|
$197M |
Sector Composition
| 1 | Financials | 17.87% |
| 2 | Healthcare | 17.83% |
| 3 | Technology | 16.43% |
| 4 | Consumer Discretionary | 15.13% |
| 5 | Industrials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cardinal Health
CAH
$35.5B
| $31.3M | 0.07% |
406,577
-853,063
| -68% | -$65.6M |
|
277
Cooper Companies
COO
$13.4B
| $31.1M | 0.07% |
+94,003
| New | +$31.1M |
|
278
Tenaris
TS
$18.9B
| $31.1M | 0.07% |
+883,433
| New | +$31.1M |
|
279
Petrobras
PBR
$79.9B
| $30.8M | 0.07% |
2,889,602
+2,258,525
| +358% | +$24.1M |
|
280
Rogers Corp
ROG
$1.42B
| $30.6M | 0.07% |
256,625
+188,149
| +275% | +$22.5M |
|
281
Freshpet
FRPT
$2.72B
| $30.4M | 0.07% |
575,516
+165,906
| +41% | +$8.75M |
|
|
NEWR
282
DELISTED
New Relic, Inc.
NEWR
| $30.3M | 0.07% |
536,217
-3,719
| -0.7% | -$210K |
|
283
Dave & Buster's
PLAY
$888M
| $30.2M | 0.07% |
853,374
+325,260
| +62% | +$11.5M |
|
284
ResMed
RMD
$40.2B
| $30M | 0.07% |
144,184
+39,768
| +38% | +$8.28M |
|
285
iShares Short Treasury Bond ETF
SHV
$20.8B
| $30M | 0.07% |
+273,000
| New | +$30M |
|
286
Biohaven
BHVN
$1.63B
| $29.9M | 0.07% |
2,157,767
+870,417
| +68% | +$12.1M |
|
287
Aramark
ARMK
$10.3B
| $29.9M | 0.07% |
723,791
+292,280
| +68% | +$12.1M |
|
288
Sociedad Química y Minera de Chile
SQM
$13B
| $29.9M | 0.07% |
374,671
+31,675
| +9% | +$2.53M |
|
289
Clearfield
CLFD
$450M
| $29.7M | 0.07% |
315,759
+313,493
| +13,835% | +$29.5M |
|
290
Celldex Therapeutics
CLDX
$1.47B
| $29.7M | 0.07% |
666,749
+14,028
| +2% | +$625K |
|
291
Comstock Resources
CRK
$4.73B
| $29.3M | 0.07% |
2,138,740
-26,269
| -1% | -$360K |
|
292
Calix
CALX
$3.88B
| $29.1M | 0.07% |
425,856
-62,796
| -13% | -$4.3M |
|
293
Lufax Holding
LU
$2.55B
| $29M | 0.07% |
14,930,009
+2,336,516
| +19% | +$4.53M |
|
294
Garmin
GRMN
$46.5B
| $28.9M | 0.07% |
313,576
-68,632
| -18% | -$6.33M |
|
295
Clarivate
CLVT
$2.92B
| $28.9M | 0.07% |
3,464,602
+1,284,389
| +59% | +$10.7M |
|
296
Vale
VALE
$43.9B
| $28.8M | 0.06% |
+1,697,806
| New | +$28.8M |
|
|
EOCW
297
DELISTED
Elliott Opportunity II Corp.
EOCW
| $28.8M | 0.06% |
2,857,509
| – | – |
|
298
Hims & Hers Health
HIMS
$9.57B
| $28.8M | 0.06% |
4,487,038
+2,236,609
| +99% | +$14.3M |
|
299
T Rowe Price
TROW
$23.6B
| $28.5M | 0.06% |
261,413
+257,897
| +7,335% | +$28.1M |
|
300
Abercrombie & Fitch
ANF
$4.46B
| $28.5M | 0.06% |
1,242,070
+507,957
| +69% | +$11.6M |
|